Is GINA Worth the Wait?

5 Pages Posted: 31 Oct 2009 Last revised: 6 Nov 2012

See all articles by Mark A. Rothstein

Mark A. Rothstein

University of Louisville - Institute for Bioethics, Health Policy, and Law; University of Louisville - Louis D. Brandeis School of Law

Date Written: March 1, 2008

Abstract

It has been pending in Congress for twelve years, despite the support of the last Presedential Adminstrations and the National Institutes of Health. It has been the subject of extensive lobbying by acedemic medical centers, pharmaceutical and biotech companies, genetic advocacy groups, and civil rights organizations. It has overcome vehement objections by employers and insurers. Its final passage however, has been thwarted by a few Congressional leaders, who have prevented enactment despite overwhelming bi-patisian support in both houses of Congress.

Suggested Citation

Rothstein, Mark A., Is GINA Worth the Wait? (March 1, 2008). Journal of Law, Medicine and Ethics, Vol. 36, No. 1, 2008. Available at SSRN: https://ssrn.com/abstract=1497023

Mark A. Rothstein (Contact Author)

University of Louisville - Institute for Bioethics, Health Policy, and Law ( email )

Louisville, KY 40202
United States

HOME PAGE: http://www.louisville.edu/bioethics

University of Louisville - Louis D. Brandeis School of Law ( email )

Wilson W. Wyatt Hall
Louisville, KY 40292
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
43
Abstract Views
642
PlumX Metrics